1770 – Valve-in-valve transcatheter aortic valve implantation using a balloon-expanding transcatheter heart valve system for patients with severe, symptomatic aortic stenosis

Page last updated: 01 February 2024

Application Detail

Description of Medical Service

Valve- in-valve transcatheter aortic valve implantation (ViV TAVI) is a procedure that can be used to replace a patient’s aortic valve. It is less invasive than open heart surgery. The process involves a replacement aortic valve being inserted via an artery using a guidewire. The valve is then expanded using a balloon catheter. Once the valve is in place the balloon is deflated, and the catheter and guidewire are removed.

Description of Medical Condition

Aortic valve stenosis is a type of heart valve disease, whereby the valve between the lower left heart chamber and the aorta is narrowed and doesn't fully open. This reduces or blocks blood flow from the heart to the aorta and to the rest of the body. The condition requires surgery to repair or replace the valve, and without treatment can lead to death.

The specific population for the proposed service in this application is patients with severe, symptomatic aortic stenosis, who have previously undergone surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) but are now experiencing symptomatic structural valve deterioration (SVD), with the bioprosthetic aortic valve failing and resulting in stenosis, insufficiency or both. These patients require a repeat aortic valve replacement, and have been judged by a heart team, including a cardiothoracic surgeon, to be at high risk for open heart surgery.

Reason for Application

Amendment to MBS item

Medical Service Type

Therapeutic technology

Previous Application Number/s

Not Applicable

Associated Documentation

Application Summary and PICO Set

Application Summary (PDF 380 KB)
Application Summary (Word 23 KB)

PICO Set 1 (PDF 854 KB)
PICO Set 1 (Word 288 KB)

PICO Set 2 (PDF 855 KB)
PICO Set 2 (Word 287 KB)

Consultation Survey

Consultation Survey (PDF 654 KB)
Consultation Survey (Word 32 KB)

PASC Consultation
PASC consultation closes 15 March 2024

MSAC Consultation
MSAC consultation TBA – please subscribe to the MSAC Email Bulletin to be notified when consultation opens for this application

For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process

PICO Confirmation

-

Assessment Report

-

Public Summary Document

-

Meetings for this Application

PASC

18–19 April 2024

ESC

-

MSAC

-